Interesting that in both this article and the NY Mag article they don’t actually interview anyone who believes that LC is actually a biological disease—don’t know why the editors let them do this—this isn’t really journalism—it’s opinion writing based on misinformation.
From Q & A, sounds like Astellas weren’t seeing (interim) data they liked from the Bocidelpar (ASP0367) trial, so they ended it, but data will still be analyzed. But there were no safety issues.
Great question!
David Sabatini needs a job—serious comment. He has worked on mTOR/rapamycin. Don’t want to litigate the baggage here https://en.m.wikipedia.org/wiki/David_M._Sabatini
Need buy-in from Arc Institute to focus on MECFS— these folks https://arcinstitute.org/team I tried to get...
Also not enrolling any more patients for Muscular Dystrophy trial for the same drug.
https://www.parentprojectmd.org/wp-content/uploads/2022/11/PPMD-clean_Astellas-0367-CL-0102-Community-Newsletter-to-DMD-community-003.pdf
Merged thread
Making this its own thread because this is big news. And a big disappointment.
This was the $8 million dollar trial sponsored by The Japanese company Astellas.
Here is a note I got in response to an email I sent to OMF—they in turn forwarded me a short note from Systrom.
“From...
Functional medicine is a pseudoscience.
https://sciencebasedmedicine.org/functional-medicine-reams-of-useless-tests-in-one-hand-a-huge-invoice-in-the-other/
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.